SCHEDULE FILED TO REPORT ACQUISITION OF BENEFICIAL OWNERSHIP

Company

Cellectar Biosciences, Inc.

Filed

June 10, 2020

Accession Number

0001387131-20-005563

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →